{"id":51684,"date":"2026-02-22T19:46:10","date_gmt":"2026-02-22T19:46:10","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/pd1-and-pdl1-inhibitors-market-mordor\/"},"modified":"2026-10-30T17:52:14","modified_gmt":"2026-10-30T08:52:14","slug":"pd1-and-pdl1-inhibitors-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/pd1-and-pdl1-inhibitors-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/pd1-and-pdl1-inhibitors-market_1706787560125_PD1.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/pd1-and-pdl1-inhibitors-market-size-image-1771399763207.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ub2e4\uc591\ud55c \uc885\uc591 \uc720\ud615\uc5d0 \uac78\uce5c \uc784\uc0c1 \uc801\uc6a9 \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.2 \uba74\uc5ed\ud56d\uc554\uc81c\uc5d0 \ub300\ud55c \uc6b0\ud638\uc801\uc778 \uaddc\uc81c \uacbd\ub85c<\/li>\n<li class=\"toc-level-3\">4.2.3 \ubcd1\uc6a9 \uba74\uc5ed \uc694\ubc95\uc758 \uc218\uc6a9 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc608\uce21 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc0f \uc9c4\ub2e8 \uae30\uc220\uc758 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.5 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc99d\uac00\ud558\ub294 \uc885\uc591\ud559 \uc758\ub8cc \uc9c0\ucd9c<\/li>\n<li class=\"toc-level-3\">4.2.6 \uba74\uc5ed\ud56d\uc554 \ubd84\uc57c\uc758 \ud30c\ud2b8\ub108\uc2ed \ubc0f \ub77c\uc774\uc120\uc2a4 \uacc4\uc57d \uc99d\uac00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub2e8\uc77c\ud074\ub860\ud56d\uccb4\uc758 \ub192\uc740 \uac1c\ubc1c \ubc0f \uc81c\uc870 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc8fc\uc694 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c\uc758 \ub3c5\uc810\uad8c \uc0c1\uc2e4 \uc784\ubc15<\/li>\n<li class=\"toc-level-3\">4.3.3 \ube44\uc6a9 \ud6a8\uc728\uc131\uc5d0 \ub300\ud55c \uc5c4\uaca9\ud55c \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc0c8\ub85c\uc6b4 \uba74\uc5ed\uad00\ubb38 \uc870\uc808 \ubc29\uc2dd\uc73c\ub85c\ubd80\ud130\uc758 \uacbd\uc7c1 \uc2ec\ud654<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc5b5\uc81c\uc81c \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 PD-1 \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.2 PD-L1 \uc5b5\uc81c\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ube44\uc18c\uc138\ud3ec\ud3d0\uc554<\/li>\n<li class=\"toc-level-3\">5.2.2 \ud751\uc0c9\uc885<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc2e0\uc7a5\uc554<\/li>\n<li class=\"toc-level-3\">5.2.4 \ud638\uc9c0\ud0a8 \ub9bc\ud504\uc885<\/li>\n<li class=\"toc-level-3\">5.2.5 \uae30\ud0c0 \uc554<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc720\ud1b5 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubcd1\uc6d0 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc18c\ub9e4 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc628\ub77c\uc778 \uc57d\uad6d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.4.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.4.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.4.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.4.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.4.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.4.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.4.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.4.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.4.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.4.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.4.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.4.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.4.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.4.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 {(\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)}\n<ul>\n<li class=\"toc-level-3\">6.3.1 Akeso Inc.<\/li>\n<li class=\"toc-level-3\">6.3.2 Amgen Inc.<\/li>\n<li class=\"toc-level-3\">6.3.3 Arcus Biosciences<\/li>\n<li class=\"toc-level-3\">6.3.4 AstraZeneca PLC<\/li>\n<li class=\"toc-level-3\">6.3.5 BeiGene Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.6 Bristol-Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.3.7 Coherus BioSciences<\/li>\n<li class=\"toc-level-3\">6.3.8 Daiichi Sankyo Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.9 Eli Lilly And Co.<\/li>\n<li class=\"toc-level-3\">6.3.10 F. Hoffmann-La Roche AG<\/li>\n<li class=\"toc-level-3\">6.3.11 GSK Plc<\/li>\n<li class=\"toc-level-3\">6.3.12 Henlius Biotech<\/li>\n<li class=\"toc-level-3\">6.3.13 Hengrui Medicine<\/li>\n<li class=\"toc-level-3\">6.3.14 Innovent Biologics<\/li>\n<li class=\"toc-level-3\">6.3.15 Leap Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.16 Merck &amp; Co.<\/li>\n<li class=\"toc-level-3\">6.3.17 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.18 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.19 Regeneron Pharmaceuticals Inc.<\/li>\n<li class=\"toc-level-3\">6.3.20 Sanofi SA<\/li>\n<li class=\"toc-level-3\">6.3.21 Shanghai Junshi Biosciences<\/li>\n<li class=\"toc-level-3\">6.3.22 Zai Lab Ltd.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c \uc2dc\uc7a5 \uac1c\uc694 (2026-2031)<\/p>\n<p># 1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd<\/p>\n<p>PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc740 2025\ub144 621\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec, 2026\ub144 741\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144\uc5d0\ub294 1,420\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 13.88%\ub85c \uc131\uc7a5\ud560 \uac83\uc774\ub77c\ub294 \uc608\uce21\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c \ubd80\uc0c1\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \ubd81\ubbf8\ub294 \uc5ec\uc804\ud788 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud560 \uac83\uc785\ub2c8\ub2e4. \ud604\uc7ac \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc73c\ub85c \ud3c9\uac00\ub429\ub2c8\ub2e4.<\/p>\n<p># 2. \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c\uc5d0 \ub300\ud55c \uc218\uc694\ub294 \ubcf4\uc870 \ubc0f \uc2e0\ubcf4\uc870 \uc694\ubc95\uc73c\ub85c\uc758 \uc801\uc751\uc99d \ud655\ub300, \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\ubc18 \ucc98\ubc29\uc758 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc8fc\uc785 \uc694\ubc95\uc5d0 \ub300\ud55c \uc6b0\ud638\uc801\uc778 \ubcf4\ud5d8 \uc815\ucc45\uc5d0 \ud798\uc785\uc5b4 \uacac\uace0\ud558\uac8c \uc720\uc9c0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 1\uc138\ub300 \ube0c\ub79c\ub4dc\uc758 \ub3c5\uc810\uad8c \uc0c1\uc2e4\uc774 \uc784\ubc15\ud558\uace0 \ubcf4\ud5d8\uc0ac\ub4e4\uc774 \ube44\uc6a9 \ud6a8\uc728\uc131\uc5d0 \ub300\ud55c \uac15\ub825\ud55c \uc99d\uac70\ub97c \uc694\uad6c\ud558\uba74\uc11c 2024\ub144 \uc774\uc804 \ub300\ube44 \uc131\uc7a5\uc138\uac00 \ub2e4\uc18c \ub454\ud654\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc138 \uc644\ud654\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0, \uc870\ud569 \uba74\uc5ed\uc694\ubc95\uc758 \ubc1c\uc804, \ud53c\ud558 \uc81c\ud615\uc758 \uac1c\ubc1c, \uadf8\ub9ac\uace0 \uc9c0\ub9ac\uc801 \uc811\uadfc\uc131 \ud655\ub300\ub85c \uc778\ud574 PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc740 \uc7a5\uae30\uc801\uc778 \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc744 \uc9c0\uc18d\uc801\uc73c\ub85c \ubcf4\uc5ec\uc8fc\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1 \ud658\uacbd\uc740 \ub354\uc6b1 \uce58\uc5f4\ud574\uc9c0\uace0 \uc788\uc73c\uba70, \uc911\uad6d \uc81c\uc870\uc5c5\uccb4\ub4e4\uc740 \ub2e4\uad6d\uc801 \uae30\uc5c5 \ub300\ube44 40-60% \ub0ae\uc740 \uac00\uaca9\uc73c\ub85c \uc2dc\uc7a5\uc5d0 \uc9c4\uc785\ud558\uace0 \uc788\uc73c\uba70, 2027\ub144\ubd80\ud130\ub294 \ucd5c\uc18c 8\uac1c \uc774\uc0c1\uc758 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uac00 3\uc0c1 \uc784\uc0c1 \ud504\ub85c\uadf8\ub7a8\uc744 \ud1b5\ud574 \ucd9c\uc2dc\ub97c \ubaa9\ud45c\ub85c \ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 3. \uc8fc\uc694 \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825 (Drivers)<\/p>\n<p>*   \ub2e4\uc591\ud55c \uc885\uc591 \uc720\ud615\uc73c\ub85c\uc758 \uc784\uc0c1 \uc801\uc6a9 \ud655\ub300 (+3.2%): \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c\ub294 \uc804\uc774\uc131 \uc9c8\ud658 \uce58\ub8cc\ub97c \ub118\uc5b4 \ucd08\uae30 \ub2e8\uacc4 \uc9c8\ud658\uc73c\ub85c \uc801\uc6a9 \ubc94\uc704\uac00 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 5\uc6d4, FDA\ub294 \uc808\uc81c\ub41c IB-IIIa\uae30 \ube44\uc18c\uc138\ud3ec\ud3d0\uc554(NSCLC)\uc5d0 \ub300\ud55c \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9\uc758 \ubcf4\uc870 \uc694\ubc95\uc744 \uc2b9\uc778\ud558\uc5ec \uc5f0\uac04 \uc57d 8\ub9cc 5\ucc9c \uba85\uc758 \ubbf8\uad6d \ud658\uc790\uc5d0\uac8c \ucd94\uac00\uc801\uc778 \uce58\ub8cc \uae30\ud68c\ub97c \uc81c\uacf5\ud588\uc2b5\ub2c8\ub2e4. \ub354\ubc1c\ub8e8\ub9d9\uc740 2025\ub144 3\uc6d4 \uc81c\ud55c\uc801 \uc18c\uc138\ud3ec\ud3d0\uc554\uc5d0 \ub300\ud55c \uc801\uc751\uc99d\uc744 \ud655\ubcf4\ud588\uc73c\uba70, MSI-H \ubc0f TMB-H \uace0\ud615\uc554\uc5d0 \ub300\ud55c \uc885\uc591 \ubd88\ubb38 \uc2b9\uc778 \ub610\ud55c \uc2dc\uc7a5 \ud655\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uba74\uc5ed\ud56d\uc554\uc81c\uc5d0 \ub300\ud55c \uc6b0\ud638\uc801\uc778 \uaddc\uc81c \uacbd\ub85c (+2.1%): FDA\uc758 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815(Breakthrough Therapy) \ubc0f EMA\uc758 PRIME \uc81c\ub3c4\uc640 \uac19\uc740 \uc2e0\uc18d \uc2b9\uc778 \uacbd\ub85c\ub294 \uba74\uc5ed\ud56d\uc554\uc81c \uac1c\ubc1c\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 11\uc6d4, Arcus Biosciences\ub294 PD-L1 \uace0\ubc1c\ud604 \uc804\uc774\uc131 NSCLC\uc5d0 \ub300\ud55c \ub3d4\ubc14\ub0a0\ub9ac\ub9d9 + \uc9d0\ubca0\ub810\ub9ac\ub9d9 \uc870\ud569\uc758 \uac00\uc18d \uc2b9\uc778\uc744 \ud68d\ub4dd\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc2e0\uc18d \uc2b9\uc778 \uc81c\ub3c4\ub294 \ucd08\uae30 \uc790\ubcf8 \uc704\ud5d8\uc744 \uc904\uc774\uc9c0\ub9cc, \uc8fc\uc694 \uc784\uc0c1 \ubaa9\ud45c \ubbf8\ub2ec \uc2dc \uc2b9\uc778 \ucca0\ud68c \uac00\ub2a5\uc131\ub3c4 \ub0b4\ud3ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc870\ud569 \uba74\uc5ed\uc694\ubc95\uc758 \uc218\uc6a9 \uc99d\uac00 (+2.8%): PD-L1 \ubc1c\ud604\uc774 \ub0ae\uac70\ub098 \uba74\uc5ed\ud559\uc801\uc73c\ub85c &#8220;\ucc28\uac00\uc6b4&#8221; \uc885\uc591 \ubbf8\uc138\ud658\uacbd\uc5d0\uc11c \uc774\uc911 \uccb4\ud06c\ud3ec\uc778\ud2b8 \ucc28\ub2e8, \uba74\uc5ed\ud56d\uc554\uc81c-\ud654\ud559\uc694\ubc95, \uba74\uc5ed\ud56d\uc554\uc81c-TKI \ubcd1\uc6a9 \uc694\ubc95\uc774 \ub2e8\ub3c5 \uc694\ubc95\uc744 \ub300\uccb4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub2c8\ubcfc\ub8e8\ub9d9\uacfc \uc774\ud544\ub9ac\ubb34\ub9d9 \uc870\ud569\uc740 \uc911\ub4f1\ub3c4 \ub610\ub294 \ubd88\ub7c9 \uc704\ud5d8 \uc2e0\uc7a5\uc138\ud3ec\uc554(RCC)\uc5d0\uc11c 55.7\uac1c\uc6d4\uc758 \uc911\uc559\uac12 \uc804\uccb4 \uc0dd\uc874\uc728(OS)\uc744 \uc785\uc99d\ud558\uba70 \uc635\ub514\ubcf4(Opdivo) \ub9e4\ucd9c\uc5d0 \uae30\uc5ec\ud588\uc2b5\ub2c8\ub2e4. \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9\uacfc \ud654\ud559\uc694\ubc95 \ubcd1\uc6a9\uc740 1\ucc28 \uc804\uc774\uc131 NSCLC \uce58\ub8cc\uc758 62%\ub97c \ucc28\uc9c0\ud558\uba70 5\ub144 \uc0dd\uc874\uc728 \ud61c\ud0dd\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc608\uce21 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc0f \uc9c4\ub2e8 \ubc1c\uc804 (+1.9%): 2024\ub144 FDA Blueprint \ud504\ub85c\uc81d\ud2b8 \uc774\ud6c4 PD-L1 \uba74\uc5ed\uc870\uc9c1\ud654\ud559 \ubd84\uc11d\uc758 \uc77c\uce58\ub3c4\uac00 85-92%\ub85c \ud5a5\uc0c1\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc21c\ud658 \uc885\uc591 DNA(ctDNA) \ubaa8\ub2c8\ud130\ub9c1\uc740 \uc9c8\ubcd1 \uc9c4\ud589 \uc608\uce21\uc5d0 78%\uc758 \ubbfc\uac10\ub3c4\ub97c \ubcf4\uc5ec \uc870\uae30 \uce58\ub8cc \uc870\uc815\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. \ub85c\uc288-\ud328\uc2a4AI \ud30c\ud2b8\ub108\uc2ed\uacfc \uac19\uc740 \uacf5\uac04 \uc804\uc0ac\uccb4\ud559 \ubd84\uc57c\uc758 \uc804\ub7b5\uc801 \ud611\ub825\uc740 2027\ub144\uae4c\uc9c0 \uc0c1\uc6a9\ud654\ub420 \uc608\uc815\uc785\ub2c8\ub2e4.<br \/>\n*   \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc99d\uac00\ud558\ub294 \uc885\uc591\ud559 \uc758\ub8cc \uc9c0\ucd9c (+2.5%): \ud2b9\ud788 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \uc911\uc18c\ub4dd \uad6d\uac00\uc5d0\uc11c \uc885\uc591\ud559 \uad00\ub828 \uc758\ub8cc \uc9c0\ucd9c\uc774 \uac00\uc18d\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc57c\uc758 \ud30c\ud2b8\ub108\uc2ed \ubc0f \ub77c\uc774\uc120\uc2a4 \uacc4\uc57d \uc99d\uac00 (+1.4%): \ubbf8\uad6d-EU-\uc911\uad6d \ud601\uc2e0 \ud5c8\ube0c\ub97c \uc911\uc2ec\uc73c\ub85c \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc57c\uc758 \ud30c\ud2b8\ub108\uc2ed \ubc0f \ub77c\uc774\uc120\uc2a4 \uacc4\uc57d\uc774 \ud65c\ubc1c\ud558\uac8c \uc774\ub8e8\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 4. \uc8fc\uc694 \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>*   \ub2e8\uc77c\ud074\ub860\ud56d\uccb4 \uac1c\ubc1c \ubc0f \uc81c\uc870\uc758 \ub192\uc740 \ube44\uc6a9 (-1.7%): \ub2e8\uc77c\ud074\ub860\ud56d\uccb4\uc758 \uac1c\ubc1c \ubc0f \uc81c\uc870\uc5d0 \ub4dc\ub294 \ub192\uc740 \ube44\uc6a9\uc740 \ud2b9\ud788 \uc778\ud504\ub77c\uac00 \uc81c\ud55c\uc801\uc778 \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<br \/>\n*   \uc120\ub3c4\uc801\uc778 \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c\uc758 \ub3c5\uc810\uad8c \uc0c1\uc2e4 \uc784\ubc15 (-2.3%): \ub2c8\ubcfc\ub8e8\ub9d9\uc758 \ud575\uc2ec \ud56d\uccb4 \ud2b9\ud5c8\ub294 2026\ub144 7\uc6d4\uc5d0, \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9\uc758 \ud2b9\ud5c8\ub294 2028\ub144 6\uc6d4(\uc18c\uc544 \uc5f0\uc7a5 \uc2dc 2028\ub144 12\uc6d4)\uc5d0 \ub9cc\ub8cc\ub429\ub2c8\ub2e4. 8\uac1c \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uac00 3\uc0c1 \uc784\uc0c1 \ub2e8\uacc4\uc5d0 \uc788\uc73c\uba70, FDA\uc758 2024\ub144 \uc678\uc0bd \uc9c0\uce68\uc73c\ub85c \uc778\ud574 \ub2e4\uc911 \uc801\uc751\uc99d \ucd9c\uc2dc\uac00 \ucd5c\ub300 18\uac1c\uc6d4 \uc9c0\uc5f0\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ubbf8\uad6d \uc2dc\uc7a5\uc5d0\uc11c\ub294 \ucd9c\uc2dc \ud6c4 2\ub144\uac04 \uc21c\uac00\uaca9\uc774 25-30% \ud558\ub77d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ube44\uc6a9 \ud6a8\uc728\uc131\uc5d0 \ub300\ud55c \uc5c4\uaca9\ud55c \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00 (HTA) (-1.2%): \uc720\ub7fd\uc758 NICE, G-BA, HAS\uc640 \uce90\ub098\ub2e4, \ud638\uc8fc \ub4f1\uc5d0\uc11c\ub294 \ube44\uc6a9 \ud6a8\uc728\uc131\uc5d0 \ub300\ud55c \uc5c4\uaca9\ud55c \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00\uac00 \uc774\ub8e8\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, NICE\ub294 \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9-\ud654\ud559\uc694\ubc95\uc758 \uc0bc\uc911 \uc74c\uc131 \uc720\ubc29\uc554 \uce58\ub8cc\ub97c \ucd08\uae30\uc5d0\ub294 \uac70\ubd80\ud588\uc73c\ub098, 45%\uc758 \uae30\ubc00 \ud560\uc778 \ud6c4 \uc7a0\uc815 \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc0c8\ub85c\uc6b4 \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc591\uc2dd\uacfc\uc758 \uacbd\uc7c1 \uc2ec\ud654 (-0.9%): \uc0c8\ub85c\uc6b4 \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc870\uc808 \ubc29\uc2dd\uc758 \ub4f1\uc7a5\uc740 \uc2dc\uc7a5 \uacbd\uc7c1\uc744 \ub354\uc6b1 \uc2ec\ud654\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 5. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p> 5.1. \uc5b5\uc81c\uc81c \uc720\ud615\ubcc4: PD-1 \uc81c\uc81c \uc9c0\ubc30, PD-L1 \uc5b5\uc81c\uc81c \uac00\uc18d\ud654<\/p>\n<p>*   PD-1 \uc81c\uc81c: 2025\ub144 \ub9e4\ucd9c\uc758 80.92%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9\uc740 20\uac1c \uc774\uc0c1\uc758 \uc801\uc751\uc99d\uc5d0\uc11c \ub9ac\ub354\uc2ed\uc744 \ubc1c\ud718\ud558\uace0 \uc788\uc73c\uba70, \ub2c8\ubcfc\ub8e8\ub9d9\uc740 \ud751\uc0c9\uc885 \ubc0f \uc2e0\uc7a5\uc138\ud3ec\uc554(RCC) \ubd84\uc57c\uc5d0\uc11c \ud655\uace0\ud55c \uc785\uc9c0\ub97c \ub2e4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. PD-1 \uc81c\uc81c \uc2dc\uc7a5\uc740 2026\ub144 600\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 1,081\uc5b5 \ub2ec\ub7ec\ub85c 12.7%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   PD-L1 \uc5b5\uc81c\uc81c: \uc5f0\uac04 15.43%\uc758 \uc131\uc7a5\ub960\ub85c \uc804\uccb4 \uc2dc\uc7a5 \uc131\uc7a5\ub960\uc744 \uc0c1\ud68c\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ub354\ubc1c\ub8e8\ub9d9\uc740 \uc808\uc81c \ubd88\uac00\ub2a5\ud55c 3\uae30 NSCLC\uc5d0\uc11c \uadf8 \uc5ed\ud560\uc744 \uacf5\uace0\ud788 \ud558\uace0 \uc788\uc73c\uba70, \uc544\ud14c\uc878\ub9ac\uc8fc\ub9d9-\ubca0\ubc14\uc2dc\uc8fc\ub9d9\uc740 47\uac1c\uad6d\uc5d0\uc11c \uac04\uc138\ud3ec\uc554(HCC) \uce58\ub8cc\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. \ub354\ubc1c\ub8e8\ub9d9\uc740 2024\ub144 \uae00\ub85c\ubc8c \ub9e4\ucd9c 32\uc5b5 \ub2ec\ub7ec\ub97c \ub2ec\uc131\ud588\uc73c\uba70, \uc544\ud14c\uc878\ub9ac\uc8fc\ub9d9\uc740 2025\ub144 \uc911\ubc18\uae4c\uc9c0 1\ucc28 HCC \uce58\ub8cc \uc2dc\uc791\uc758 48%\ub97c \uc810\uc720\ud588\uc2b5\ub2c8\ub2e4. \ud53c\ud558 \uc81c\ud615\uc758 \uac1c\ubc1c\uc740 \uc678\ub798 \ub610\ub294 \uc7ac\ud0dd \uce58\ub8cc\ub85c\uc758 \uc804\ud658 \uac00\ub2a5\uc131\uc744 \uc5f4\uc5b4\uc8fc\uba70 \ucd94\uac00\uc801\uc778 \uc131\uc7a5 \ub3d9\ub825\uc774 \ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 5.2. \uc801\uc6a9 \ubd84\uc57c\ubcc4: NSCLC \ud575\uc2ec \uc720\uc9c0, \uc2e0\uc7a5\uc554 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5<\/p>\n<p>*   \ube44\uc18c\uc138\ud3ec\ud3d0\uc554(NSCLC): 2025\ub144 \ub9e4\ucd9c\uc758 42.05%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\uc804\ud788 \ud575\uc2ec \uc801\uc6a9 \ubd84\uc57c\uc785\ub2c8\ub2e4. \ub192\uc740 \ubc1c\ubcd1\ub960\uacfc \ubc14\uc774\uc624\ub9c8\ucee4 \uac80\uc0ac\uc758 \ubcf4\ud3b8\uc131\uc774 \uc774\ub97c \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9 \uae30\ubc18 \ud654\ud559\uc694\ubc95 \ubcd1\uc6a9\uc740 PD-L1 \uc800\ubc1c\ud604 \ud658\uc790\uad70\uc5d0\uc11c \uc9c0\ubc30\uc801\uc778 \uce58\ub8cc\ubc95\uc73c\ub85c \uc790\ub9ac \uc7a1\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uc7a5\uc554: 2025\ub144 \ub9e4\ucd9c\uc758 9%\uc5d0 \ubd88\uacfc\ud558\uc9c0\ub9cc, \uc774\uc911 \uccb4\ud06c\ud3ec\uc778\ud2b8 \ubc0f IO-TKI \uc694\ubc95\uc758 \ubc1c\uc804\uc73c\ub85c 2026-2031\ub144 \ub3d9\uc548 15.87%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub2c8\ubcfc\ub8e8\ub9d9-\uc774\ud544\ub9ac\ubb34\ub9d9\uc758 \uc9c0\uc18d\uc801\uc778 \ud6a8\uacfc\uc640 \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9-\ub80c\ubc14\ud2f0\ub2d9\uc758 71% \uac1d\uad00\uc801 \ubc18\uc751\ub960(ORR)\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 \uc2dc\uc7a5 \uc810\uc720\uc728\uc774 \ub450 \ubc30\ub85c \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uae30\ud0c0: \ud751\uc0c9\uc885, \ud638\uc9c0\ud0a8 \ub9bc\ud504\uc885, \uc870\uc9c1 \ubd88\ubb38 MSI-H\/TMB-H \uc801\uc751\uc99d \ub4f1\ub3c4 \uc2dc\uc7a5 \ud655\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 5.3. \uc720\ud1b5 \ucc44\ub110\ubcc4: \ubcd1\uc6d0 \uc57d\uad6d \uc9c0\ubc30, \uc628\ub77c\uc778 \uc57d\uad6d \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc5d0\uc11c \ubd80\uc0c1<\/p>\n<p>*   \ubcd1\uc6d0 \uc57d\uad6d: 2025\ub144 \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c \ubb3c\ub7c9\uc758 68.32%\ub97c \uc870\ub2ec\ud558\uba70 \uc5ec\uc804\ud788 \uc9c0\ubc30\uc801\uc778 \uc720\ud1b5 \ucc44\ub110\uc785\ub2c8\ub2e4. \uc774\ub294 \ubbf8\uad6d \uba54\ub514\ucf00\uc5b4 \ud30c\ud2b8 B\uc758 \uad6c\ub9e4 \ubc0f \uccad\uad6c \uacbd\uc81c\uc131\uacfc \uc804 \uc138\uacc4\uc801\uc778 \uc8fc\uc785 \uc778\ud504\ub77c\uc5d0 \uc758\ud574 \uc720\uc9c0\ub429\ub2c8\ub2e4.<br \/>\n*   \uc18c\ub9e4 \uc804\ubb38 \uc57d\uad6d: 14%\uc758 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc628\ub77c\uc778 \uc57d\uad6d: \ud604\uc7ac 7.7%\uc758 \ub0ae\uc740 \uc810\uc720\uc728\uc744 \ubcf4\uc774\uc9c0\ub9cc, 2031\ub144\uae4c\uc9c0 16.21%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uac70\uc758 \uc804\uc801\uc73c\ub85c \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc5d0\uc11c \uc774\ub8e8\uc5b4\uc9c8 \uac83\uc785\ub2c8\ub2e4. \uc911\uad6d\uc758 JD Health\uc640 \uc778\ub3c4\uc758 PharmEasy\ub294 \uc6d0\uaca9 \uc885\uc591\ud559 \uc0c1\ub2f4\uacfc \ucf5c\ub4dc\uccb4\uc778 \ubc30\uc1a1\uc744 \uc5f0\uacc4\ud558\uace0 \uc788\uc73c\uba70, \ud5a5\ud6c4 \ud53c\ud558 \uc81c\ud488\uc774 \ucd9c\uc2dc\ub418\uace0 \uaddc\uc81c \ub2f9\uad6d\uc774 \uc7ac\ud0dd \ud22c\uc5ec\ub97c \ud5c8\uc6a9\ud55c\ub2e4\uba74 \uc628\ub77c\uc778 \uc720\ud1b5\uc758 \uc131\uc7a5\uc740 \ub354\uc6b1 \uac00\uc18d\ud654\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ubbf8\uad6d FDA\uc758 \uc8fc\uc785 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc6b0\ud3b8 \uc8fc\ubb38 \uae08\uc9c0 \uaddc\uc815\uc740 \uace0\uc18c\ub4dd \uc2dc\uc7a5\uc5d0\uc11c\uc758 \ub514\uc9c0\ud138 \uce68\ud22c\ub97c \uc81c\ud55c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 6. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \ub9e4\ucd9c\uc758 43.21%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uba54\ub514\ucf00\uc5b4 \ubcf4\ud5d8 \uc801\uc6a9\uacfc \ubc00\uc9d1\ub41c \uc784\uc0c1 \uc2dc\ud5d8 \uc778\ud504\ub77c\uc5d0 \ud798\uc785\uc740 \uacb0\uacfc\uc785\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc778\ud50c\ub808\uc774\uc158 \uac10\ucd95\ubc95(IRA)\uc5d0 \ub530\ub77c 2027\ub144\ubd80\ud130 \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9 \uac00\uaca9 \ud611\uc0c1\uc774 \uc2dc\uc791\ub420 \uc608\uc815\uc774\uc5b4\uc11c \ubbf8\uad6d \ub9e4\ucd9c \uc131\uc7a5\ub960\uc774 \uc911\ubc18 \ud55c \uc790\ub9bf\uc218\ub85c \uac10\uc18c\ud560 \uac00\ub2a5\uc131\uc774 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: 28%\uc758 \uc810\uc720\uc728\ub85c \ub450 \ubc88\uc9f8\ub85c \ud070 \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \ub3c5\uc77c\uacfc \ud504\ub791\uc2a4\ub294 &#8220;\uc0c1\ub2f9\ud55c&#8221; \ub610\ub294 &#8220;\uc911\uc694\ud55c&#8221; \ud61c\ud0dd \ub4f1\uae09\uc744 \ubd80\uc5ec\ud558\uc5ec \ube44\uad50 \ub300\uc0c1 \ub300\ube44 15-28%\uc758 \ud504\ub9ac\ubbf8\uc5c4\uc744 \ud5c8\uc6a9\ud558\ub294 \ubc18\uba74, \uc601\uad6d\uc740 \uc0c1\ub2f9\ud55c \uae30\ubc00 \ud560\uc778\uc744 \uc694\uad6c\ud569\ub2c8\ub2e4. \uc774\ud0c8\ub9ac\uc544\uc758 \uad00\ub9ac\ud615 \uc9c4\uc785 \uacc4\uc57d\uacfc \uc2a4\ud398\uc778\uc758 \uc9e7\uc740 \ubcf4\ud5d8 \uc801\uc6a9 \uc9c0\uc5f0\uc740 3\ucc28 \uc758\ub8cc\uae30\uad00\uc744 \ub118\uc5b4\uc120 \uce68\ud22c\ub97c \uc6a9\uc774\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 14.65%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d\uc758 \uad6d\ub0b4 4\ub300 \ube0c\ub79c\ub4dc(\ud2f0\uc2ac\ub810\ub9ac\uc8fc\ub9d9, \uc2e0\ud2f8\ub9ac\ub9d9, \ud1a0\ub9ac\ud314\ub9ac\ub9d9, \uc138\ub974\ud50c\ub8e8\ub9ac\ub9d9)\ub294 \ub2e4\uad6d\uc801 \uae30\uc5c5 \ub300\ube44 40-60% \ud560\uc778\ub41c \uac00\uaca9\uc73c\ub85c \uc804\uad6d \ubcf4\ud5d8 \uc801\uc6a9\uc744 \ubc1b\uc73c\uba70 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc740 \ubcf4\uc870\uae08 \uc0c1\ud55c\uc120\uc744 \ud655\ub300\ud558\uc5ec \ud658\uc790 \ubcf8\uc778 \ubd80\ub2f4\uae08\uc744 1\/3\ub85c \uc904\uc5ec \uace0\ub839\uce35\uc758 \uce58\ub8cc \uc2dc\uc791\uc744 \ucd09\uc9c4\ud588\uc2b5\ub2c8\ub2e4. \uc778\ub3c4\ub294 \ud604\uc9c0 \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 3\uc0c1 \uc5f0\uad6c\ub97c \uc2b9\uc778\ud588\uc73c\uba70, 2027\ub144\uae4c\uc9c0 60% \ub0ae\uc740 \ube44\uc6a9\uc73c\ub85c \ucd9c\uc2dc\ub418\uc5b4 \uacf5\uacf5 \ubcd1\uc6d0\uae4c\uc9c0 \uc811\uadfc\uc131\uc744 \ud655\ub300\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8: \uc774 \ub450 \uc9c0\uc5ed\uc740 \ud569\uccd0\uc11c 6%\uc758 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4. UAE\ub294 2024\ub144 \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9\uc744 \uc804\uad6d\uc801\uc73c\ub85c \ub4f1\uc7ac\ud588\uc73c\uba70, \ub0a8\uc544\ud504\ub9ac\uce74 \uacf5\ud654\uad6d\uc740 \uba38\ud06c\uc640 \uae30\uc220 \uc774\uc804 \uacc4\uc57d\uc744 \uccb4\uacb0\ud558\uc5ec 70% \ub0ae\uc740 \uac00\uaca9\uc73c\ub85c \ud604\uc9c0 \uc0dd\uc0b0\uc744 \ucd94\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ube0c\ub77c\uc9c8 ANVISA\ub294 \uc0c8\ub85c\uc6b4 \uc801\uc751\uc99d\uc744 \uc2b9\uc778\ud588\uc9c0\ub9cc, SUS(\ud1b5\ud569 \ubcf4\uac74 \uc2dc\uc2a4\ud15c) \ubcf4\ud5d8 \uc801\uc6a9\uc740 \uc544\uc9c1 \uacc4\ub958 \uc911\uc774\uc5b4\uc11c \ubbfc\uac04 \ubcf4\ud5d8 \ud658\uc790\uc5d0\uac8c\ub9cc \uc811\uadfc\uc774 \uc81c\ud55c\uc801\uc785\ub2c8\ub2e4.<\/p>\n<p># 7. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uba38\ud06c(Merck), \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb), \ub85c\uc288(Roche), \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74(AstraZeneca), \ubca0\uc774\uc9c4(BeiGene)\uc774 2024\ub144 \ub9e4\ucd9c\uc758 78%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\uac00 \ub192\uc740 \uc591\uc0c1\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4. \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9 \ub2e8\ub3c5\uc73c\ub85c \uc57d 1\/3\uc744 \ucc28\uc9c0\ud588\uc73c\ub098, \uba38\ud06c\ub294 \ubbf8\uad6d \ubc95\uc5d0 \ub530\ub978 \uac00\uaca9 \ud611\uc0c1\uacfc 2028\ub144 12\uc6d4 \ud2b9\ud5c8 \ub9cc\ub8cc\uc5d0 \uc9c1\uba74\ud574 \uc788\uc2b5\ub2c8\ub2e4. BMS\ub294 \ubc14\uc774\uc624\uc5d4\ud14d(BioNTech)\uacfc PD-L1\u00d7VEGF-A \uc774\uc911\ud2b9\uc774\ud56d\uccb4\uc5d0 \ub300\ud55c 15\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uacc4\uc57d\uc744 \uccb4\uacb0\ud558\uba70 \ub300\uc751\ud558\uace0 \uc788\uc73c\uba70, \ub85c\uc288\ub294 TIGIT \uc2e4\ud328 \uc774\ud6c4 \ud53c\ud558 \uc544\ud14c\uc878\ub9ac\uc8fc\ub9d9\uc73c\ub85c \uc810\uc720\uc728 \ubc29\uc5b4\ub97c \ubaa8\uc0c9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uad6d \uae30\uc5c5\ub4e4\uc740 \uc9c0\ubc29 \uc785\ucc30\uacfc \ub0ae\uc740 \ube44\uc6a9\uc744 \ud65c\uc6a9\ud558\uc5ec \uad6d\ub0b4 \uc2dc\uc7a5 \ub9ac\ub354\uc2ed\uc744 \ud655\ubcf4\ud55c \ud6c4 \uae00\ub85c\ubc8c \uc8fc\uc694 \uae30\uc5c5\uc5d0 \uc11c\uad6c \uc2dc\uc7a5 \ucd9c\uc2dc \ub77c\uc774\uc120\uc2a4\ub97c \ubd80\uc5ec\ud558\ub294 \uc804\ub7b5\uc744 \uc0ac\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uc704\ud611: \uc554\uc820(Amgen), \uc0b0\ub3c4\uc2a4(Sandoz), \uc0bc\uc131\ubc14\uc774\uc624\uc5d0\ud53c\uc2a4(Samsung Bioepis) \ub4f1\uc740 3\uc0c1 \uc784\uc0c1 \ud504\ub85c\uadf8\ub7a8\uc744 \uc9c4\ud589 \uc911\uc774\uba70, \uc131\uacf5 \uc2dc \uc774\ub974\uba74 2027\ub144 \ub9d0 \uc720\ub7fd \uc2dc\uc7a5\uc5d0 \uc9c4\ucd9c\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. FDA\uc758 \uc801\uc751\uc99d\ubcc4 \uc678\uc0bd \uc694\uad6c \uc0ac\ud56d\uc73c\ub85c \uc778\ud574 \ubbf8\uad6d \ucd9c\uc2dc\uac00 \uc9c0\uc5f0\ub420 \uc218 \uc788\uc9c0\ub9cc, 25-30%\uc758 \uc21c\uac00\uaca9 \uc778\ud558\uac00 \uc608\uc0c1\ub418\uc5b4 \uae30\uc874 \uae30\uc5c5\ub4e4\uc5d0\uac8c \uc555\ub825\uc744 \uac00\ud560 \uac83\uc785\ub2c8\ub2e4. \uc774\uc5d0 \ub530\ub77c \ud53c\ud558 \uc81c\ud615, \uace0\uc815 \uc6a9\ub7c9 \uc870\ud569, \uc774\uc911\ud2b9\uc774\ud56d\uccb4 \uad6c\uc870\uac00 \ud575\uc2ec\uc801\uc778 \ucc28\ubcc4\ud654 \uc694\uc18c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ucd08\uae30 \ud30c\uc774\ud504\ub77c\uc778 \uacbd\uc7c1\uc790: Arcus\uc758 \ub3d4\ubc14\ub0a0\ub9ac\ub9d9-\uc9d0\ubca0\ub810\ub9ac\ub9d9\uc740 2024\ub144 FDA \uac00\uc18d \uc2b9\uc778\uc744 \ud68d\ub4dd\ud588\uc73c\uba70, Regeneron\uc740 \ud53c\uc548\ub9ac\ub9d9-\uc138\ubbf8\ud50c\ub9ac\ub9d9\uc5d0 \ub300\ud574 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4. 3\uc0c1 \ub370\uc774\ud130\uc5d0\uc11c \ub192\uc740 ORR\uc774 \uc7ac\ud604\ub420 \uacbd\uc6b0, \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc9c4\uc785\uc5d0 \uc55e\uc11c \ud2c8\uc0c8 \uc2dc\uc7a5\uc774 \uae30\uc874 PD-1 \ub2e8\ub3c5 \uc694\ubc95\uc5d0\uc11c \ubc97\uc5b4\ub098 \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 8. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2026\ub144 1\uc6d4: \uc885\uc591\ud559 \uc804\ubb38 \uc81c\uc57d\ud68c\uc0ac\uc778 \uce74\uc9c0\uc544 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Kazia Therapeutics)\ub294 NDL2 \uac1c\ubc1c\uc744 \ub4b7\ubc1b\uce68\ud558\ub294 \uc804\uc784\uc0c1 \ubc0f \uc911\uac1c \ub370\uc774\ud130\ub97c \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4. NDL2\ub294 \uae30\uc874 PD-1\/PD-L1 \ud56d\uccb4\ub85c\ub294 \ud574\uacb0\ub418\uc9c0 \uc54a\ub294 \uba74\uc5ed\uc694\ubc95 \ub0b4\uc131 \ubc0f \uc804\uc774 \uc9c4\ud589\uc758 \uc138\ud3ec \ub0b4 \ub3d9\uc778\uc778 \ud575 PD-L1\uc744 \uc120\ud0dd\uc801\uc73c\ub85c \uc81c\uac70\ud558\ub3c4\ub85d \uc124\uacc4\ub41c \uc7a0\uc7ac\uc801\uc778 \uacc4\uc5f4 \ub0b4 \ucd5c\ucd08 \ub2e8\ubc31\uc9c8 \ubd84\ud574\uc81c\uc785\ub2c8\ub2e4.<br \/>\n*   2025\ub144 5\uc6d4: \uc804 \uc138\uacc4 \uc554 \uba74\uc5ed\uc694\ubc95 \uc811\uadfc\uc131 \ud655\ub300\ub97c \ubaa9\ud45c\ub85c \ud558\ub294 \uc784\uc0c1 \ub2e8\uacc4 \ubc14\uc774\uc624\uc81c\uc57d \ubca4\ucc98\uc778 OmRx Oncology\ub294 \ube44\uc18c\uc138\ud3ec\ud3d0\uc554(NSCLC) \ud658\uc790\ub97c \ub300\uc0c1\uc73c\ub85c \uacbd\uad6c\uc6a9 PD-L1 \uc5b5\uc81c\uc81c OX-4224\uc758 2\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8 \uac1c\uc2dc\ub97c \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 8\uc6d4: FDA\ub294 \uc9c4\ud589\uc131 \uc790\uad81\ub0b4\ub9c9\uc554\uc5d0 \ub300\ud55c \ub3c4\uc2a4\ud0c0\ub9ac\ub9d9(dostarlimab) + \uce74\ubcf4\ud50c\ub77c\ud2f4-\ud30c\ud074\ub9ac\ud0c1\uc140 \ubcd1\uc6a9 \uc694\ubc95\uc744 \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4. \uc774 \uc694\ubc95\uc740 \uc0ac\ub9dd \uc704\ud5d8\uc744 36% \uac10\uc18c\uc2dc\ucf30\uc73c\uba70, \ucd5c\uace0 \ub9e4\ucd9c\uc774 10\uc5b5 \ub2ec\ub7ec\ub97c \ub118\uc5b4\uc124 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uc804 \uc138\uacc4 PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c\ub294 \uc138\ud3ec \ud45c\uba74\uc758 PD-1 \ubc0f PD-L1 \uba74\uc5ed \uccb4\ud06c\ud3ec\uc778\ud2b8 \ub2e8\ubc31\uc9c8 \ud65c\uc131\uc744 \ucc28\ub2e8\ud558\ub294 \uc0c8\ub85c\uc6b4 \uba74\uc5ed \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c \ud56d\uc554\uc81c\ub85c, \uc5ec\ub7ec \uc720\ud615\uc758 \uc554\uc5d0 \ub300\ud55c \ucd5c\uc804\uc120 \uba74\uc5ed \uce58\ub8cc\uc81c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \uc804\ub9dd<br \/>\n\ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \uc804 \uc138\uacc4 PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc740 2026\ub144 741\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 1,420\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud558\uc5ec \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 13.88%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ud2b9\ud788 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc911\uad6d\uc758 \uad6d\ub0b4 PD-1 \ube0c\ub79c\ub4dc \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300\uc640 \uc77c\ubcf8\uc758 \uace0\uac00 \uc758\uc57d\ud488 \ubcf4\uc870\uae08 \ud655\ub300\ub85c \uc778\ud574 14.65%\uc758 \uac00\uc7a5 \uac15\ub825\ud55c CAGR\uc744 \ubcf4\uc774\uba70 \uc2dc\uc7a5 \ud655\uc7a5\uc744 \uc8fc\ub3c4\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \ub3d9\uc778<br \/>\n\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \u25b2\ub2e4\uc591\ud55c \uc885\uc591 \uc720\ud615\uc5d0 \uac78\uce5c \uc784\uc0c1 \uc801\uc6a9 \ud655\ub300 \u25b2\uba74\uc5ed \ud56d\uc554\uc81c\uc5d0 \ub300\ud55c \uc6b0\ud638\uc801\uc778 \uaddc\uc81c \uacbd\ub85c \u25b2\ubcd1\uc6a9 \uba74\uc5ed \uc694\ubc95\uc758 \uc218\uc6a9 \uc99d\uac00 \u25b2\uc608\uce21 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc0f \uc9c4\ub2e8 \uae30\uc220 \ubc1c\uc804 \u25b2\uc804 \uc138\uacc4\uc801\uc778 \uc554 \uc758\ub8cc \uc9c0\ucd9c \uc99d\uac00 \u25b2\uba74\uc5ed \ud56d\uc554 \ubd84\uc57c\uc758 \ud30c\ud2b8\ub108\uc2ed \ubc0f \ub77c\uc774\uc120\uc2f1 \uacc4\uc57d \uc99d\uac00 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<br \/>\n\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \u25b2\ub2e8\uc77c\ud074\ub860 \ud56d\uccb4\uc758 \ub192\uc740 \uac1c\ubc1c \ubc0f \uc81c\uc870 \ube44\uc6a9 \u25b2\uc120\ub3c4\uc801\uc778 \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c\uc758 \ud2b9\ud5c8 \ub3c5\uc810\uad8c \uc0c1\uc2e4 \uc784\ubc15 \u25b2\ube44\uc6a9 \ud6a8\uc728\uc131\uc5d0 \ub300\ud55c \uc5c4\uaca9\ud55c \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00(HTA) \u25b2\uc0c8\ub85c\uc6b4 \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc591\uc2dd\uc73c\ub85c\ubd80\ud130\uc758 \uacbd\uc7c1 \uc2ec\ud654 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \ub2c8\ubcfc\ub8e8\ub9d9(Nivolumab)\uc758 \ud575\uc2ec \ud2b9\ud5c8\ub294 2026\ub144 7\uc6d4\uc5d0 \ub9cc\ub8cc\ub418\uba70, \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9(Pembrolizumab)\uc758 \ubb3c\uc9c8 \ud2b9\ud5c8\ub294 2028\ub144 6\uc6d4(\uc18c\uc544\uacfc \uc5f0\uc7a5 \uc2dc 2028\ub144 12\uc6d4)\uc5d0 \ub9cc\ub8cc\ub420 \uc608\uc815\uc785\ub2c8\ub2e4. \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uccb4\ud06c\ud3ec\uc778\ud2b8 \uc5b5\uc81c\uc81c \ucd9c\uc2dc \ud6c4 \ubbf8\uad6d \uc21c\uac00\uaca9\uc740 2\ub144 \uc774\ub0b4\uc5d0 25-30% \ud558\ub77d\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>4. \uc8fc\uc694 \uc751\uc6a9 \ubd84\uc57c \ubc0f \uc2dc\uc7a5 \ub3d9\ud5a5<br \/>\n\ud604\uc7ac \ube44\uc18c\uc138\ud3ec\ud3d0\uc554(NSCLC)\uc774 \uc804 \uc138\uacc4 PD-1 \ubc0f PD-L1 \uc5b5\uc81c\uc81c \uc0ac\uc6a9\ub7c9\uc758 \uc57d 42%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc218\uc694\ub97c \ucc3d\ucd9c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 1\ucc28 \ubcd1\uc6a9 \uc694\ubc95 \ubc0f \ubcf4\uc870 \uc720\uc9c0 \uc694\ubc95\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub429\ub2c8\ub2e4. \ub610\ud55c, \ud658\uc790 \uce5c\ud654\uc801\uc778 \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615\uc758 \uac1c\ubc1c\ub3c4 \uc9c4\ud589 \uc911\uc774\uba70, \ub85c\uc288(Roche)\uc758 5\ubd84 \ud53c\ud558 \uc544\ud14c\uc878\ub9ac\uc8fc\ub9d9(atezolizumab)\uc740 3\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8 \uc911\uc73c\ub85c 2026\ub144 \ub9d0 \ucd9c\uc2dc\ub97c \ubaa9\ud45c\ub85c \ud558\uace0 \uc788\uc5b4, \uac00\uc815 \ub610\ub294 \uc18c\ub9e4 \ud074\ub9ac\ub2c9 \ud22c\uc5ec\uac00 \uac00\ub2a5\ud574\uc9c8 \uc804\ub9dd\uc785\ub2c8\ub2e4.<\/p>\n<p>5. \uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \ubd84\uc11d \ubc94\uc704<br \/>\n\ubcf4\uace0\uc11c\ub294 \uc5b5\uc81c\uc81c \uc720\ud615(PD-1 \uc5b5\uc81c\uc81c, PD-L1 \uc5b5\uc81c\uc81c), \uc751\uc6a9 \ubd84\uc57c(\ube44\uc18c\uc138\ud3ec\ud3d0\uc554, \ud751\uc0c9\uc885, \uc2e0\uc7a5\uc554, \ud638\uc9c0\ud0a8 \ub9bc\ud504\uc885, \uae30\ud0c0 \uc554), \uc720\ud1b5 \ucc44\ub110(\ubcd1\uc6d0 \uc57d\uad6d, \uc18c\ub9e4 \uc57d\uad6d, \uc628\ub77c\uc778 \uc57d\uad6d) \ubc0f \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc804 \uc138\uacc4 \uc8fc\uc694 17\uac1c\uad6d\uc758 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \ub3d9\ud5a5\uc744 \ud3ec\ud568\ud558\uba70, \uac00\uce58(USD \ubc31\ub9cc)\ub97c \uae30\uc900\uc73c\ub85c \ud569\ub2c8\ub2e4. \ub610\ud55c, \uac00\uce58\/\uacf5\uae09\ub9dd \ubd84\uc11d, \uaddc\uc81c \ud658\uacbd, \uae30\uc220 \uc804\ub9dd, \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d \ub4f1 \ud3ec\uad04\uc801\uc778 \uc2dc\uc7a5 \ud658\uacbd \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<br \/>\n\uacbd\uc7c1 \ud658\uacbd \uc139\uc158\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d \ubc0f Akeso Inc., AstraZeneca PLC, Bristol-Myers Squibb, Merck &#038; Co., Pfizer Inc. \ub4f1 \uc8fc\uc694 22\uac1c \uae30\uc5c5\uc5d0 \ub300\ud55c \uc0c1\uc138 \ud504\ub85c\ud544\uc744 \ub2e4\ub8f9\ub2c8\ub2e4. \uac01 \uae30\uc5c5\uc758 \uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5\uc801 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n<p>7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<br \/>\n\ubcf4\uace0\uc11c\ub294 \ubbf8\uac1c\ucc99 \uc2dc\uc7a5(White-Space) \ubc0f \ubbf8\ucda9\uc871 \uc218\uc694(Unmet-Need) \ud3c9\uac00\ub97c \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-51684","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/51684"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=51684"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/51684\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=51684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=51684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=51684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}